![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Antiviral Effect of MK-1439, a Novel NNRTI, (+Truvada®)
in ART-Naive HIV Infected Patients
|
|
|
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
J. O. Morales-Ramirez1, J. M. Gatell2, D. P. Hagins3,
M. Thompson4, K. Arasteh5, C. Hoffmann6, C. Harvey7,
X. Xu7, H. Teppler7 for the P007 Study Team
1Clinical Research Puerto Rico, San Juan, PR; 2Hospital Clinic/IDIBAPS. Univ of Barcelona, Spain; 3Chatham County Health Dept, Savannah, GA, USA; 4AIDS Research Consortium of Atlanta, GA, USA; 5EPIMED/Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; 6ICH Study Center, Hamburg, Germany; 7Merck & Co., Inc., Whitehouse Station, NJ, USA
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
![CROI1.gif](../images/030514/030514-7/CROI1.gif)
![CROI2.gif](../images/030514/030514-7/CROI2.gif)
![CROI3.gif](../images/030514/030514-7/CROI3.gif)
![CROI4.gif](../images/030514/030514-7/CROI4.gif)
![CROI5.gif](../images/030514/030514-7/CROI5.gif)
![CROI6.gif](../images/030514/030514-7/CROI6.gif)
![CROI7.gif](../images/030514/030514-7/CROI7.gif)
![CROI8.gif](../images/030514/030514-7/CROI8.gif)
![CROI9.gif](../images/030514/030514-7/CROI9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|